SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Sales for the quarter ended September 2021 of Rs. 5267.27 millions rose by 27.92% from Rs. 4117.78 millions.A slim rise of 24.54% was recorded in the Net profit for the quarter ended September 2021 to Rs. 883.99  millions  From Rs. 709.83 millions.Operating profit surged to 1342.43 millions from the corresponding previous quarter of 1139.24 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 5267.27 4117.78 27.92 10730.28 9014.02 19.04 18919.96 16407.44 15.31
Other Income 195.61 81.88 138.90 324.43 307.23 5.60 1118.89 493.43 126.76
PBIDT 1342.43 1139.24 17.84 3054.29 2946.15 3.67 6682.54 4175.88 60.03
Interest 11.84 16.96 -30.19 20.69 54.27 -61.88 71.92 29.35 145.04
PBDT 1330.59 1122.28 18.56 3033.60 2891.88 4.90 6610.62 4046.53 63.37
Depreciation 153.99 171.40 -10.16 328.78 341.07 -3.60 673.55 650.91 3.48
PBT 1176.60 950.88 23.74 2704.82 2550.81 6.04 5937.07 3395.62 74.84
TAX 292.61 241.05 21.39 667.71 621.72 7.40 1466.23 714.18 105.30
Deferred Tax 22.61 5.55 307.39 17.71 11.72 51.11 91.23 -106.02 -186.05
PAT 883.99 709.83 24.54 2037.11 1929.09 5.60 4470.84 2681.44 66.73
Equity 154.56 154.56 0.00 154.56 154.56 0.00 154.56 154.56 0.00
PBIDTM(%) 25.49 27.67 -7.88 28.46 32.68 -12.91 35.32 25.45 38.78

JB Chem & Pharma Share Price

1997.35 22.65 (1.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×